Damato, B., Dukes, J., Goodall, H., & Carvajal, R. (2019). Tebentafusp: T cell redirection for the treatment of metastatic uveal melanoma. MDPI.
Citación estilo ChicagoDamato, BE, J. Dukes, H. Goodall, and RD Carvajal. Tebentafusp: T Cell Redirection for the Treatment of Metastatic Uveal Melanoma. MDPI, 2019.
Cita MLADamato, BE, et al. Tebentafusp: T Cell Redirection for the Treatment of Metastatic Uveal Melanoma. MDPI, 2019.
Warning: These citations may not always be 100% accurate.